| Report ID | Date of report | Patient age | Patient gender |
| 168002 | Jul, 20, 2006 | 45 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Somavert | pegvisomant |
| Name |
Blood Growth Hormone Decreased |
Blood Growth Hormone Increased |
Cough |
Fatigue |
Insulin-like Growth Factor Decreased |
Insulin-like Growth Factor Increased |
Laryngeal Dyspnoea |
Laryngitis |
Laryngospasm |
Musculoskeletal Discomfort |
Oedema |
Paraesthesia |
Pituitary Tumour Benign |
Spinal Disorder |
Urticaria |
Vocal Cord Paralysis |
Results from eHealthMe : 222 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Blood Growth Hormone Decreased | 1 (0.45%) |
Blood Growth Hormone Increased | 3 (1.35%) |
Cough | 1 (0.45%) |
Fatigue | 9 (4.05%) |
Insulin-like Growth Factor Decreased | 2 (0.90%) |
Insulin-like Growth Factor Increased | 7 (3.15%) |
Laryngeal Dyspnoea | 1 (0.45%) |
Laryngitis | 1 (0.45%) |
Laryngospasm | 3 (1.35%) |
Musculoskeletal Discomfort | 1 (0.45%) |
Oedema | 3 (1.35%) |
Paraesthesia | 1 (0.45%) |
Pituitary Tumour Benign | 10 (4.50%) |
Spinal Disorder | 1 (0.45%) |
Urticaria | 6 (2.70%) |
Vocal Cord Paralysis | 1 (0.45%) |
Top 3 (total: 104. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Levothyroxine Sodium | 40 (6.53%) |
Hydrocortisone | 26 (4.24%) |
Testosterone | 24 (3.92%) |
Death reported: 0
| Name | Count (% of total reports) |
Headache | 19 (8.56%) |
Cholelithiasis | 13 (5.86%) |
Asthenia | 10 (4.50%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
